Cargando…

High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma

AIMS: To evaluate the clinical significance of coatomer protein complex subunit beta 2 (COPB2) in patients with glioma using a bioinformatics analysis. METHODS: Oncomine, GEO, and The Cancer Genome Atlas databases were used to examine the COPB2 transcript levels in glioma tissues. Gene expression pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yan, Wang, Xuan, Huang, Xing, Li, Xu‐Dong, Cheng, Kai, Yu, Hao, Zhou, Yu‐Jie, Lv, Peng, Jiang, Xiao‐Bing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081167/ https://www.ncbi.nlm.nih.gov/pubmed/31710183 http://dx.doi.org/10.1111/cns.13254

Ejemplares similares

COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC
por: Zhang, Jiayao, et al.
Publicado: (2021)

An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors
por: Wu, Biao, et al.
Publicado: (2021)

Early prediction of COVID‐19 severity using extracellular vesicle COPB2
por: Fujita, Yu, et al.
Publicado: (2021)

Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis
por: Chen, Taiqin, et al.
Publicado: (2022)

OSBPL2 Is Required for the Binding of COPB1 to ATGL and the Regulation of Lipid Droplet Lipolysis
por: Wang, Tianming, et al.
Publicado: (2020)

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
por: Yu, Kai, et al.
Publicado: (2022)

Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma
por: Zhou, Guojin, et al.
Publicado: (2022)

COPB2: a transport protein with multifaceted roles in cancer development and progression
por: Feng, Y., et al.
Publicado: (2021)

Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway
por: Feng, Yanyan, et al.
Publicado: (2022)

SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer
por: Liu, Aiyu, et al.
Publicado: (2020)

Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway
por: An, Caixia, et al.
Publicado: (2019)

COPB2 promotes metastasis and inhibits apoptosis of lung adenocarcinoma cells through functioning as a target of miR-216a-3p
por: Wang, Mingxue, et al.
Publicado: (2020)

Detection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens
por: Christodoulou, Eleni G., et al.
Publicado: (2017)

The Role of the Moraxella catarrhalis CopB Protein in Facilitating Iron Acquisition From Human Transferrin and Lactoferrin
por: Chan, Clement, et al.
Publicado: (2021)

Biallelic variants in COPB1 cause a novel, severe intellectual disability syndrome with cataracts and variable microcephaly
por: Macken, William L., et al.
Publicado: (2021)

Silencing the COPB2 gene decreases the proliferation, migration and invasion of human triple-negative breast cancer cells
por: Wu, Wencheng, et al.
Publicado: (2021)

SYST-23 CDK1 AS AN INDEPENDENT PROGNOSTIC INDICATOR AND POTENTIAL THERAPEUTIC TARGET IN GLIOMA
por: Wang, Yu, et al.
Publicado: (2023)

Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma
por: Dong, Tianyu, et al.
Publicado: (2022)

Potential Epigenetic-Based Therapeutic Targets for Glioma
por: Zang, Lanlan, et al.
Publicado: (2018)

COPB2 is up‐regulated in breast cancer and plays a vital role in the metastasis via N‐cadherin and Vimentin
por: Bhandari, Adheesh, et al.
Publicado: (2019)

CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
por: Tu, Yiming, et al.
Publicado: (2017)

Calcyphosine promotes the proliferation of glioma cells and serves as a potential therapeutic target
por: Zhu, Zheng, et al.
Publicado: (2021)

Correction to: CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

TIMM44 is a potential therapeutic target of human glioma
por: Guo, Yi-zhuo, et al.
Publicado: (2022)

CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2021)

Identification of potential therapeutic targets for gliomas by bioinformatics analysis
por: Ma, Ke, et al.
Publicado: (2017)

GPX8 as a Novel Prognostic Factor and Potential Therapeutic Target in Primary Glioma
por: Yang, Zhao-shou, et al.
Publicado: (2022)

Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease
por: Long, Xiong-Quan, et al.
Publicado: (2023)

Chrysin Induced Cell Apoptosis Through H19/let-7a/COPB2 Axis in Gastric Cancer Cells and Inhibited Tumor Growth
por: Chen, Lin, et al.
Publicado: (2021)

COPB2 suppresses cell proliferation and induces cell cycle arrest in human colon cancer by regulating cell cycle-related proteins
por: Wang, Yan, et al.
Publicado: (2018)

COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway
por: Wang, Yan, et al.
Publicado: (2020)

Transforming growth factor β: A potential biomarker and therapeutic target of ventricular remodeling
por: Ma, Yuan, et al.
Publicado: (2017)

The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma
por: Irshad, Khushboo, et al.
Publicado: (2023)

Expression and potential role of FOSB in glioma
por: Qi, Min, et al.
Publicado: (2022)

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting
por: Cockle, J V, et al.
Publicado: (2015)

IDH mutation in glioma: molecular mechanisms and potential therapeutic targets
por: Han, Sue, et al.
Publicado: (2020)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
por: Zhu, Zhengyang, et al.
Publicado: (2022)

TMIGD2 as a potential therapeutic target in glioma patients
por: Boulhen, Chaimae, et al.
Publicado: (2023)

S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma
por: Zhang, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqdvn7g4ogrjov5utm8uscji6d